PITTSBURGH (KDKA) -- For type 2 diabetes, how about a shot that's just once a week? The FDA is considering a medicine that would be a weekly shot. And it's not insulin. It's a hormone called albiglutide -- to be marketed by Glaxo Smith Kline as Eperzan. "It lowers blood glucose...
“weekly injections can be burdensome for patients,” megret said. “a single shot a month could make it much easier for people living with diabetes or obesity to stick to their drug regimens, improving quality of life and reducing side effects and diabetes complications.” t...
PITTSBURGH (KDKA) -- For type 2 diabetes, how about a shot that's just once a week?The FDA is considering a medicine that would be a weekly shot. And it's not insulin.It's a hormone called albiglutide -- to be marketed by Glaxo Smith Kline as Eperzan."It lowers blood glucose le...
The ONWARDS 5 trial randomly assigned 1,085 insulin-naïve adults with type 2 diabetes in seven countries to either weekly icodec titrated with a dosing guide app (icodec with app) or once-daily basal insulin (OD analogs) dosed perstandard practice. The two groups were compared for effectiven...